Literature DB >> 2792121

Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis.

M Turpeinen1.   

Abstract

To evaluate the effect of topical hydrocortisone therapy on cortisol secretion, the plasma cortisol response to a 2 h adrenocorticotropic hormone (ACTH) test was determined in 17 children with dermatitis. Percutaneous absorption of hydrocortisone was measured in the acute phase of dermatitis by a 4 h absorption test. Two-hour plasma cortisol in the ACTH test correlated inversely with the increment of plasma cortisol in the absorption test. The duration of topical hydrocortisone therapy had no significant influence on the adrenocortical response to ACTH. A moderately or severely subnormal 2 h plasma cortisol level was observed in three infants after 3-5 months' topical therapy with hydrocortisone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792121     DOI: 10.1007/bf00443095

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  Two-hour adrenocorticotropic hormone test: accuracy in the evaluation of the hypothalamic-pituitary-adrenocortical axis.

Authors:  S Leisti; J Perheentupa
Journal:  Pediatr Res       Date:  1978-04       Impact factor: 3.756

2.  Adrenal cortical function in children on steroids.

Authors:  J A Kuzemko; J G Lines
Journal:  Arch Dis Child       Date:  1970-04       Impact factor: 3.791

3.  Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate.

Authors:  J A Keipert; R Kelly
Journal:  Med J Aust       Date:  1971-03-06       Impact factor: 7.738

4.  Pituitary adrenal function during corticosteroid withdrawal in rheumatoid arthritis.

Authors:  J R Daly; A B Myles; P A Bacon; C G Beardwell; O Savage
Journal:  Ann Rheum Dis       Date:  1967-01       Impact factor: 19.103

5.  Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children.

Authors:  M Turpeinen; E Lehtokoski-Lehtiniemi; S Leisti; O P Salo
Journal:  Pediatr Dermatol       Date:  1988-11       Impact factor: 1.588

6.  Dwarfism following long-term topical corticosteroid therapy.

Authors:  H H Bode
Journal:  JAMA       Date:  1980 Aug 22-29       Impact factor: 56.272

7.  The effect of percutaneously absorbed steroids on hypothalamic--pituitary--adrenal function after intensive use in in-patients.

Authors:  D D Munro
Journal:  Br J Dermatol       Date:  1976-03       Impact factor: 9.302

8.  Percutaneous absorption of testosterone in the newborn rhesus monkey: comparison to the adult.

Authors:  R C Wester; P K Noonan; M P Cole; H I Maibach
Journal:  Pediatr Res       Date:  1977-06       Impact factor: 3.756

9.  Morning plasma cortisol levels in infants treated with topical fluorinated glucocorticosteroids.

Authors:  W L Weston; W M Sams; H G Morris; J M Arthur; G J Blakeman; M Andresen
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

10.  Recovery of adrenocortical function during long-term treatment with corticosteroids.

Authors:  L Westerhof; M J Van Ditmars; P J Der Kinderen; J H Thijssen; F Schwarz
Journal:  Br Med J       Date:  1972-04-22
View more
  2 in total

1.  Herbal creams used for atopic eczema in Birmingham, UK illegally contain potent corticosteroids.

Authors:  H M Ramsay; W Goddard; S Gill; C Moss
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

Review 2.  Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis.

Authors:  Ning Li; Yeping Qin; Dan Dai; Pengyu Wang; Mingfei Shi; Junwei Gao; Jinsheng Yang; Wei Xiao; Ping Song; Ruodan Xu
Journal:  Front Bioeng Biotechnol       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.